OBJECTIVES: The aim of this study was to clarify the outcomes of patients who require post-pneumonectomy mechanical ventilation (PPMV).
INTRODUCTION
Of all pulmonary resections, pneumonectomy is associated with the highest risk of perioperative morbidity and mortality [1] [2] [3] [4] . Postoperative mechanical ventilation may be required for cardiopulmonary compromise or other reasons [5] [6] [7] [8] . The requirement for more than 24 h of post-pneumonectomy mechanical ventilation (PPMV) is perceived to be an ominous sign, although there is a paucity of data on short-and long-term outcomes in patients requiring PPMV. We reviewed our experience with patients who required PPMV to clarify short-and long-term outcomes.
PATIENTS AND METHODS
This study was approved by the Institutional Review Board at Mayo Clinic. The requirement for individual patient consent was waived, although 2 patients who did not give preauthorization for review of their medical records for research purposes were excluded. Between January 1994 and December 2009, 548 patients underwent pneumonectomy at Mayo Clinic, Rochester, MN. The medical records were retrospectively reviewed. There were 345 males and 203 females, with a median age of 63 (ranging from 12 to 86) years. Operative procedure was either standard pneumonectomy or extended pneumonectomy defined as reoperative thoracotomy, completion pneumonectomy, extrapleural pneumonectomy, sleeve pneumonectomy, concomitant resection of mediastinal tumours, mediastinal great vessels, diaphragm, vertebral bodies or chest wall, pneumonectomy under extracorporeal circulation and pneumonectomy with muscle transposition procedures for bronchial stump reinforcement. PPMV was defined as mechanical ventilation via an endotracheal tube following thoracotomy (continued PPMV) or reintubated and started within 30 days of the pneumonectomy (reintubated PPMV) and continued for longer than 24 h. Patients who required only non-invasive mechanical ventilation such as bilevel positive airway pressure or continuous positive airway pressure were not included in the PPMV patients. Patients who were ventilated only on the first night following pneumonectomy were not included either. 'Weaned' was defined as successful separation from mechanical ventilation (with or without the need for supplemental oxygen) at the time of hospital dismissal.
The records of all the patients who underwent pneumonectomy were analysed for age, gender, side of the pneumonectomy, indication for operation, specific procedure performed, overall survival (OS), bronchial stump reinforcement (when applicable), histopathology (benign or malignant), forced expiratory volume in 1 second (% predicted) and the need for supplemental oxygen at dismissal. In addition, the records of all PPMV patients were analysed for the indication, timing of PPMV, duration and the timing of tracheostomy if performed. Ventilatory management (including mean tidal volume referenced to ideal body weight, fraction of inhaled oxygen and positive end-expiratory pressure), fluid balance on the first day of PPMV and the use of, and route of administration of, nutrition were also abstracted. Furthermore, we recorded complications of PPMV, the outcome of PPMV and use of adjunctive therapies such as inhaled nitric oxide (NO). The institutional Acute Physiology and Chronic Health Evaluation (APACHE III) database was searched using the software provided by Cerner Corporation (Kansas City, MO, USA), and APACHE III data for the first intensive care unit (ICU) day were abstracted. APACHE data were available only for those patients admitted to the ICU. We have previously described the utility of APACHE III scores in patients undergoing pneumonectomy [9] .
For comparisons of continuous and categorical variables, the Mann-Whitney U-test and χ 2 test were used as appropriate. OS was calculated from the date of pneumonectomy and analysed with the Kaplan-Meier method and compared by the log-rank method. P-values of <0.05 were considered statistically significant. JMP Version 8 (SAS Institute, Cary, NC, USA) was used for data analyses. Only the factors with P-values less than 0.1 under univariate analysis were included in multivariate analyses.
RESULTS
In this study, of all pneumonectomy patients (N = 548), 69 (12.6%) required reintubation and mechanical ventilation (reintubated PPMV) and 22 (4.0%) required continued intubation and mechanical ventilation (continued PPMV).
Comparison of perioperative characteristics between continued PPMV, reintubated PPMV and non-PPMV patients
The perioperative characteristics, comparing continued PPMV and reintubated PPMV patients, were summarized in Table 1 . P-values in Table 1 were given in comparison of continued PPMV and reintubated PPMV. The perioperative characteristics of non-PPMV patients were also presented in Table 1 as a control. Between non-PPMV and continued PPMV patients, significant differences were noted in benign pathology (P < 0.0001), mediastinal lymph node dissection including both radical lymphadenectomy and lymph node sampling (P < 0.0001), and percentage of forced expiratory volume in 1 second (%FEV1) predicted (P < 0.0001). Between non-PPMV and reintubated PPMV patients, significant differences were noted in benign pathology (P < 0.0001), extended pneumonectomy (P < 0.0001), %FEV1 predicted (P < 0.0001) and 30-day mortality (P < 0.0001). 
Comparison of indications, managements and complications of PPMV between continued and reintubated PPMV patients
In reintubated PPMV patients, PPMV was started within postoperative day 0 to 30 with a median of post-operative day 7.
The indications for continued PPMV and reintubated PPMV are described in Table 2 , the ventilatory management of continued PPMV and reintubated PPMV are presented in Table 3 and the complications of continued PPMV and reintubated PPMV are given in Table 4 . New-onset bronchopleural fistula as a complication of PPMV was noted in 3 patients of reintubated PPMV; of these 3 patients, 2 had undergone bronchial stump reinforcements at pneumonectomy.
Comparison of overall survival following pneumonectomy between continued, reintubated and non-PPMV patients OS following pneumonectomy for continued PPMV, reintubated PPMV and non-PPMV patients is shown in Fig. 1 . In continued PPMV patients, 5-year OS rate, 10-year OS rate and median OS were 31.3%, 31.3% and 6.5 months, respectively. In reintubated PPMV patients, 5-year OS rate, 10-year OS rate and median OS were 15.3%, 10.3% and 3.2 months, respectively. In non-PPMV patients as a control, 5-year OS rate, 10-year OS rate and median OS were 38.4%, 20.5% and 35.2 months, respectively. There was a significant difference in OS between reintubated PPMV and non-PPMV patients (P < 0.0001), while there was no significant difference between reintubated PPMV and continued PPMV (P = 0.12) or between continued PPMV and non-PPMV (P = 0.35).
Potential prognostic factors of overall survival in continued PPMV and reintubated PPMV patients
Regarding continued PPMV patients, in univariate analysis, younger age (P = 0.025) was a significant factor of improved OS and a lower positive end-expiratory pressure (PEEP; P = 0.07) and use of inhaled NO (P = 0.068) showed a tendency for improved OS. However, gender, laterality, extended pneumonectomy, APACHE III score, tidal volume, fraction of inhaled oxygen, complications of PPMV, fluid balance, %FEV1 predicted, benign pathology or late period were neither significant nor showed a tendency. In multivariate analysis, none of the factors of age (P = 0.47), a lower PEEP (P = 0.87) or use of inhaled NO resulted in a significant difference or showed a tendency. Regarding reintubated PPMV patients, in univariate analysis, younger age (P = 0.003) and fraction of inhaled oxygen (P = 0.032) were significant factors of improved OS; less positive fluid balance (P = 0.053) and late period (2002-09) (P = 0.08) showed a tendency for improved OS, while none of gender, laterality, extended pneumonectomy, APACHE III score, tidal volume, complications of PPMV, %FEV1 predicted or benign pathology was significant or showed a tendency. In multivariate analysis, none of age (P = 0.88), fraction of inhaled oxygen (P = 0.40) or late period (2002-09, P = 0.24) was a significant factor but less positive fluid balance showed a tendency (P = 0.09).
Comparison of weaning from PPMV between continued and reintubated PPMV patients
The outcomes of 'weaned' versus 'failure', which includes death on mechanical ventilation and withdrawal of mechanical ventilation and ventilator-dependence, at dismissal are given in Table 5 in comparison of continued PPMV and reintubated PPMV. There were not significant differences in the two groups. In weaned patients, PPMV were continued for 1-50 days with a median of 11. Of note, 3 patients who were dependent on continued PPMV at hospital dismissal died on the 71st, 152nd and 196th day of PPMV, respectively. Also 3 patients who were dependent on reintubated PPMV at hospital dismissal died on the 31st, 98th and 103rd day of PPMV, respectively.
Potential prognostic factors of weaning from PPMV in continued PPMV and reintubated PPMV patients
Regarding continued PPMV patients, in univariate analysis, younger age (P = 0.08) showed a tendency for weaning, while none of gender, laterality, extended pneumonectomy, APACHE III score, tidal volume, PEEP, fraction of inhaled oxygen, fluid balance, complications of PPMV, %FEV1 predicted, use of NO, benign pathology or late period (2002-09) was significant or showed a tendency.
Regarding reintubated PPMV patients, in univariate analysis, younger age (P = 0.03), a lower fraction of inhaled oxygen (P = 0.005) and less positive fluid balance (P = 0.0069) were significant factors of an improved rate of weaning; female gender (P = 0.09) showed a tendency, while none of laterality, extended pneumonectomy, APACHE III score, tidal volume, PEEP, complications of PPMV, %FEV1 predicted or benign pathology was significant or showed a tendency. In multivariate analysis, none of female gender (P = 0.16), younger age (P = 0.14), a lower fraction of inhaled oxygen (P = 0.19) or less positive fluid balance (P = 0.25) was significant or showed a tendency.
DISCUSSION
Of all pulmonary resections, a pneumonectomy is the most highrisk procedure [1, 2] . Hence, pneumonectomy is associated with prolonged continued endotracheal intubation and mechanical ventilation for cardiopulmonary compromise, which is, in turn, a risk factor of reintubation after extubation [5] . While prolonged intubation is required in 1.2% of patients undergoing pneumonectomy for lung cancer, pnuemonectomy for benign disease is noted for a trend to a high risk of complication [5] [6] [7] with the rate of prolonged endotracheal intubation and mechanical ventilation as high as 13% [10] . Regarding reintubation and mechanical ventilation, there are a few articles to date that report the incidence of 3.6-9% [6, 10, 11] in pneumonectomy for benign disease.
The aim of this study was to characterize the clinical backgrounds, outcomes and potential prognostic factors of improved clinical outcomes in patients requiring PPMV. We hypothesized that patients who continued to be intubated on mechanical ventilation following thoracotomy for pneumonectomy were different in backgrounds and outcomes from those who were reintubated for cardiopulmonary compromise or other reasons within 30 days of pneumonectomy. Therefore, we divided patients requiring PPMV into two patient groups, continued PPMV and reintubated PPMV, as reported and analysed separately in previous articles [6, 10, 11] .
Reintubation following pneumonectomy, in most cases, have specified reasons or indications such as respiratory failure, septic shock, cardiogenic shock and airway protection, which are clearly postoperative complications, while continued intubation after thoracotomy appears less frequently considered as a complication at first because prolonged ventilatory support may be required without specific indications, but simply because operating time or general anaesthesia was prolonged. In our analysis, despite the difference in APACHE III score on the first day of PPMV, clinical outcomes (OS and rate of weaning from mechanical ventilation)
were not significantly different between continued PPMV and reintubated PPMV. These results suggest that a relatively large portion of continued PPMV patients already have silent complications intraoperatively, or that continued PPMV itself is a risk factor for worse outcome [5, 11, 12] . Despite less information available in continued PPMV patients in our reports as other articles, our results suggest that we should be more careful and cautious in managing patients requiring prolonged mechanical ventilation following thoracotomy for pneumonectomy. In contrast to a tendency of improved OS of our reintubated PPMV patients in the more recent years (2002-09), there was no tendency of improvement of continued PPMV patients in the same period, although only 4 continued PPMV patients were available in the more recent years and this number was too small to find significant differences in ventilatory or other managements. Being a little more aggressive in making a diagnosis, for example, with SwanGanz catheter, may contribute to improved outcomes in continued PPMV patients in the future.
Mechanical ventilation following pulmonary resection should aim at a lower fraction of inhaled oxygen and gentle ventilation to avoid ventilator-induced barotraumas and overdistention of remaining alveoli [10] , as well as minimizing the ventilation time to avoid further ventilator-associated complications [12] . In addition to ventilatory settings, we should also pay attention to fluid management, nutrition and infection control in critical care managements. In our patient cohorts, no potential prognostic factors proved to be significant in multivariate analysis, but univariate analysis showed less positive fluid balance on the first day of PPMV and a lower fraction of inhaled oxygen tended to improve OS, which is consistent with previous reports.
Our results suggest that management of mechanical ventilation following pneumonectomy may be more challenging than in other pulmonary resections, although it is difficult to interpret our complication rate of PPMV with no similar report to compare it with. Considering that the average incidence of barotraumas following mechanical ventilation is 5-15% [13] , and that the incidence of ventilator-associated pneumonia in general was reported to be 8-28% [14] , our rates of complications of PPMV appear satisfactory. Of interest, complications of PPMV were not associated with a lower rate of weaning or worse OS in our study.
Potential alternatives to PPMV would be non-invasive ventilation (NIV) and extracorporeal membrane oxygenation (ECMO) in addition to mechanical ventilation. A portion of patients who underwent NIV for acute respiratory failure following pulmonary resection were reported to have better outcomes than undergoing conventional mechanical ventilation [15] . Although data on attempt on NIV prior to PPMV were not available in this study, we would be more conservative in NIV in place of PPMV due to a paucity of data of NIV on pneumonectomy patients [16] and a paucity of data on indications other than acute respiratory failure, such as cardiogenic shock or sepsis. Iglesias and colleagues reported efficacy of ECMO in addition to mechanical ventilation for post-pneumonectomy pulmonary oedema (PPPE) in 5 patients. ECMO for PPPE will lead to more lung-protective ventilation, stable haemodynamics and easier fluid management and, therefore, a portion of our PPPE patients might have benefited from ECMO in selected indications, although we were not able to evaluate ECMO or NIV for PPMV patients in this study. The limitations of this study included a retrospective study design with biases related to the study design, a single-centre experience and some missing intraoperative and ventilator data, which also potentially influenced the outcomes of PPMV patients. Information on neoadjuvant treatments prior to pneumonectomy is not available, but they can adversely affect pneumoenctomy or PPMV patients. In addition, ventilatory and critical care managements were not protocol-based, but dependent on each ICU consultant. NIV or ECMO was not analysed in this study.
In conclusion, our findings suggest that continued PPMV patients may have a similar rate of weaning at hospital dismissal and similar OS to reintubated PPMV patients. A lower fraction of inhaled oxygen and less positive fluid balance may be favoured managements in reintubated PPMV patients.
